RaDVaC Antiviral Database — Drugs, Trials, and Approvals Across All Viruses

Target & Classification

Virus:

EBOVEbola virus

Type:

Live attenuated vaccine

Diseases:

Ebola Virus Disease

Max Phase:

Phase 1

Phase 1

Phase 2

Phase 3

Approved

NCT ID	Phase	Disease / Condition
NCT02370589	Phase 1	Ebola Virus Disease